Regeneron Pharmaceuticals Inc (REGN)
893.50
-7.69
(-0.85%)
USD |
NASDAQ |
Apr 18, 16:00
893.71
+0.21
(+0.02%)
Pre-Market: 20:00
Regeneron Pharmaceuticals Cash and Short Term Investments (Quarterly): 10.84B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.84B |
| September 30, 2023 | 9.914B |
| June 30, 2023 | 8.928B |
| March 31, 2023 | 8.960B |
| December 31, 2022 | 7.742B |
| September 30, 2022 | 7.022B |
| June 30, 2022 | 7.566B |
| March 31, 2022 | 7.051B |
| December 31, 2021 | 5.695B |
| September 30, 2021 | 5.788B |
| June 30, 2021 | 3.911B |
| March 31, 2021 | 3.504B |
| December 31, 2020 | 3.587B |
| September 30, 2020 | 3.026B |
| June 30, 2020 | 3.144B |
| March 31, 2020 | 4.003B |
| December 31, 2019 | 3.214B |
| September 30, 2019 | 2.878B |
| June 30, 2019 | 2.670B |
| March 31, 2019 | 3.232B |
| December 31, 2018 | 2.810B |
| September 30, 2018 | 2.192B |
| June 30, 2018 | 1.684B |
| March 31, 2018 | 1.625B |
| December 31, 2017 | 1.410B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.379B |
| June 30, 2017 | 1.268B |
| March 31, 2017 | 1.307B |
| December 31, 2016 | 1.039B |
| September 30, 2016 | 1.408B |
| June 30, 2016 | 1.045B |
| March 31, 2016 | 849.18M |
| December 31, 2015 | 1.045B |
| September 30, 2015 | 895.64M |
| June 30, 2015 | 604.25M |
| March 31, 2015 | 742.16M |
| December 31, 2014 | 900.48M |
| September 30, 2014 | 1.042B |
| June 30, 2014 | 816.91M |
| March 31, 2014 | 648.13M |
| December 31, 2013 | 693.98M |
| September 30, 2013 | 445.32M |
| June 30, 2013 | 537.51M |
| March 31, 2013 | 307.71M |
| December 31, 2012 | 308.10M |
| September 30, 2012 | 262.55M |
| June 30, 2012 | 301.02M |
| March 31, 2012 | 432.30M |
| December 31, 2011 | 526.94M |
| September 30, 2011 | 245.50M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.670B
Minimum
Jun 2019
10.84B
Maximum
Dec 2023
5.760B
Average
5.695B
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 11.22B |
| Eli Lilly and Co | 2.928B |
| CytomX Therapeutics Inc | 174.51M |
| Pfizer Inc | 12.69B |
| Puma Biotechnology Inc | 95.94M |